Investor Relations

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.